BCR and chronic myelogenous leukemia, BCR-ABL1 positive: The first indication that the BCR–ABL1 fusion protein is indeed the crucial driver of CML came from mouse studies showing that expression of BCR–ABL1 in the bone marrow causes a CML-like disease (7–9).